Association of Gestational Cardiovascular Health With Pregnancy Outcomes

Condition(s) studied

Investigational drug(s) / intervention(s)

Questionnaire survey and specimen collection: Questionnaire survey, clinical follow-up and specimens collection.

Study summary

Pregnancy is a critical period for cardiovascular health risk assessment and interventions to reduce the incidence of cardiovascular disease in both mother and child generations. Recently, the American Heart Association proposed the latest cardiovascular health assessment indicator "Life's Essential 8". However, there is still a lack of application data for pregnant women. This project intends to explore the application potential of Life's Essential 8 in cardiovascular health assessment of pregnant women and establish appropriate gestaional cardiovascular health standards.

Eligibility

Primary outcome measure(s)

• Maternal outcomes — Through delivery completion, up to 42 weeks
  Including pregnancy-induced hypertension, preterm delivery, abortion, delivery way and so on. They are diagnosed by clinicians and the data is gathered from medical records.
• Neonatal outcomes — Through delivery completion, up to 42 weeks
  Birth weight（in gram), birth height (in centimetre), gestational week (in week) and other neonatal diseases. They are diagnosed by clinicians and the data is gathered from medical records.

Trial sites (3)

More Women's Hospital School Of Medicine Zhejiang University trials in China

Other trials for the same condition